BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 28098872)

  • 1. TRIM29 promotes progression of thyroid carcinoma via activating P13K/AKT signaling pathway.
    Xu J; Li Z; Su Q; Zhao J; Ma J
    Oncol Rep; 2017 Mar; 37(3):1555-1564. PubMed ID: 28098872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway.
    Zhou XM; Sun R; Luo DH; Sun J; Zhang MY; Wang MH; Yang Y; Wang HY; Mai SJ
    Oncotarget; 2016 Mar; 7(12):13634-50. PubMed ID: 26872369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA‑122 acts as tumor suppressor by targeting TRIM29 and blocking the activity of PI3K/AKT signaling in nasopharyngeal carcinoma in vitro.
    Yang Y; Li Q; Guo L
    Mol Med Rep; 2018 Jun; 17(6):8244-8252. PubMed ID: 29693120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
    Xu R; Hu J; Zhang T; Jiang C; Wang HY
    Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM29 Overexpression Promotes Proliferation and Survival of Bladder Cancer Cells through NF-κB Signaling.
    Tan ST; Liu SY; Wu B
    Cancer Res Treat; 2016 Oct; 48(4):1302-1312. PubMed ID: 26987391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCNG2 suppressor biological effects on thyroid cancer cell through promotion of CDK2 degradation.
    Li WJ; Liu GL; Yu F; Xiang XX; Lu YF; Xiao HZ; Shi YP
    Asian Pac J Cancer Prev; 2013; 14(10):6165-71. PubMed ID: 24289643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis.
    Hao NB; Tang B; Wang GZ; Xie R; Hu CJ; Wang SM; Wu YY; Liu E; Xie X; Yang SM
    Cancer Lett; 2015 May; 361(1):57-66. PubMed ID: 25727320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression.
    Kang MH; Oh SC; Lee HJ; Kang HN; Kim JL; Kim JS; Yoo YA
    Exp Cell Res; 2011 Jul; 317(12):1746-62. PubMed ID: 21570392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation.
    Guo L; Wang J; Yang P; Lu Q; Zhang T; Yang Y
    IUBMB Life; 2015 Sep; 67(9):720-5. PubMed ID: 26314828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RIP1 upregulation promoted tumor progression by activating AKT/Bcl-2/BAX signaling and predicted poor postsurgical prognosis in HCC.
    Wang C; Yao B; Xu M; Zheng X
    Tumour Biol; 2016 Nov; 37(11):15305-15313. PubMed ID: 27699664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells.
    Xiong B; Cheng Y; Ma L; Zhang C
    Int J Oncol; 2013 Jan; 42(1):219-28. PubMed ID: 23174819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastasis-Associated in Colon Cancer-1 Associates With Poor Prognosis and Promotes Cell Invasion and Angiogenesis in Human Cervical Cancer.
    Zhou X; Xu CJ; Wang JX; Dai T; Ye YP; Cui YM; Liao WT; Wu XL; Ou JP
    Int J Gynecol Cancer; 2015 Oct; 25(8):1353-63. PubMed ID: 26332389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of L1CAM is associated with tumor progression and prognosis via ERK signaling in gastric cancer.
    Ito T; Yamada S; Tanaka C; Ito S; Murai T; Kobayashi D; Fujii T; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2014 Feb; 21(2):560-8. PubMed ID: 24046108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The silencing of Pokemon attenuates the proliferation of hepatocellular carcinoma cells in vitro and in vivo by inhibiting the PI3K/Akt pathway.
    Lin CC; Zhou JP; Liu YP; Liu JJ; Yang XN; Jazag A; Zhang ZP; Guleng B; Ren JL
    PLoS One; 2012; 7(12):e51916. PubMed ID: 23300578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the novel tumor-suppressor gene CCDC67 in papillary thyroid carcinoma.
    Yin DT; Xu J; Lei M; Li H; Wang Y; Liu Z; Zhou Y; Xing M
    Oncotarget; 2016 Feb; 7(5):5830-41. PubMed ID: 26716505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of proline-rich tyrosine kinase 2 is associated with poor survival of hepatocellular carcinoma via regulating phosphatidylinositol 3-kinase/AKT pathway.
    Cao J; Chen Y; Fu J; Qian YW; Ren YB; Su B; Luo T; Dai RY; Huang L; Yan JJ; Wu MC; Yan YQ; Wang HY
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S312-23. PubMed ID: 22618716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reg4-induced mitogenesis involves Akt-GSK3β-β-Catenin-TCF-4 signaling in human colorectal cancer.
    Bishnupuri KS; Sainathan SK; Bishnupuri K; Leahy DR; Luo Q; Anant S; Houchen CW; Dieckgraefe BK
    Mol Carcinog; 2014 Feb; 53 Suppl 1(0 1):E169-80. PubMed ID: 24151146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-10b promotes migration and invasion through Hoxd10 in human gastric cancer.
    Wang YY; Li L; Ye ZY; Zhao ZS; Yan ZL
    World J Surg Oncol; 2015 Aug; 13():259. PubMed ID: 26311318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of ECM1 contributes to migration and invasion in cholangiocarcinoma cell.
    Xiong GP; Zhang JX; Gu SP; Wu YB; Liu JF
    Neoplasma; 2012; 59(4):409-15. PubMed ID: 22489696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma.
    Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC
    Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.